| Structure |
Chemical Name |
CAS |
MF |
 |
Isoprinosine |
36703-88-5 |
C24H34N6O9 |
 |
Everolimus |
159351-69-6 |
C53H83NO14 |
 |
Mizoribine |
50924-49-7 |
C9H13N3O6 |
 |
Imiquimod |
99011-02-6 |
C14H16N4 |
 |
Diacerein |
13739-02-1 |
C19H12O8 |
 |
Melatonin |
73-31-4 |
C13H16N2O2 |
 |
Rapamycin |
53123-88-9 |
C51H79NO13 |
 |
Forigerimod acetate |
1160237-55-7 |
C119H185N34O34PS |
 |
Trinecol (pullus) |
212115-71-4 |
|
 |
Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer |
189261-10-7 |
C40H55N7O11S |
 |
Atiprimod dimaleate |
183063-72-1 |
C26H48N2O4 |
 |
KZR-616 |
1629677-75-3 |
C30H42N4O8 |
 |
BMS-986166 |
1883345-06-9 |
C25H33NO2 |
 |
Briobacept |
869881-54-9 |
|
 |
Ozanimod hydrochloride |
1618636-37-5 |
C23H25ClN4O3 |
 |
Immunoglobulin G1,anti-(human CD4 (antigen)) (human-mouse monoclonal cm-T412 g1-chain), disulfide withhuman-mouse monoclonal cm-T412 k-chain, dimer |
147191-91-1 |
|
 |
PF-04171327 |
1044535-58-1 |
C29H30F3N2O5P |
 |
Lusvertikimab |
2375835-91-7 |
|
 |
Socazolimab |
2305043-30-3 |
|
 |
Bempikibart |
2622254-57-1 |
|
 |
Empasiprubart |
2579031-19-7 |
|
 |
2-acetylthiomethyl-3-(4-methylbenzoyl)propionic acid |
101973-77-7 |
C14H16O4S |
![1-Cyclopentene-1-carboxylic acid, 2-[[(3-fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-, calcium salt, hydrate (2:1:1)](/) |
1-Cyclopentene-1-carboxylic acid, 2-[[(3-fluoro-3′-methoxy[1,1′-biphenyl]-4-yl)amino]carbonyl]-, calcium salt, hydrate (2:1:1) |
2728666-90-6 |
C20H18FNO4.1/2Ca.1/2H2O |
 |
Puxitatug |
2760250-47-1 |
|
 |
6XJF4EZC5Z |
911338-45-9 |
|
![(3S,11S)-N-[(2R,3S)-2-ethoxy-5-oxo-oxolan-3-yl]-3-(isoquinoline-1-carbonylamino)-2,6-dioxo-1,7-diazabicyclo[5.4.0]undecane-11-carboxamide](/CAS/GIF/192755-52-5.gif) |
(3S,11S)-N-[(2R,3S)-2-ethoxy-5-oxo-oxolan-3-yl]-3-(isoquinoline-1-carbonylamino)-2,6-dioxo-1,7-diazabicyclo[5.4.0]undecane-11-carboxamide |
192755-52-5 |
C26H29N5O7 |
 |
RUXOPRUBART |
2842046-67-5 |
|
 |
ZanoliMuMab |
652153-01-0 |
|
 |
Sirukumab |
1194585-53-9 |
|
 |
Enoticumab |
1192578-27-0 |
|
 |
Obexelimab |
1690307-05-1 |
|
 |
Lanadelumab |
1426055-14-2 |
|
 |
Mavezelimab |
2231068-83-8 |
|
 |
Izuralimab |
2329669-80-7 |
|
 |
Domvanalimab |
2368219-35-4 |
|
 |
Avadomide hydrochloride |
1398053-45-6 |
C14H15ClN4O3 |
 |
Ianalumab |
1929549-92-7 |
|
 |
Relatlimab |
1673516-98-7 |
|
![Cyclopenta[c]pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3aα,5α,6aα)-](/CAS/20210305/GIF/1445987-21-2.gif) |
Cyclopenta[c]pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3aα,5α,6aα)- |
1445987-21-2 |
C18H22N8O2S |
 |
Rapamycin, 27-deoxo- |
186752-78-3 |
C51H81NO12 |
 |
pirazolac |
71002-09-0 |
C17H12ClFN2O2 |
 |
Pegcetacoplan |
2019171-69-6 |
|
![Cyclopenta[c]pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3aα,5α,6aα)-, sulfate (1:1)](/CAS/20211123/GIF/1639419-51-4.gif) |
Cyclopenta[c]pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3aα,5α,6aα)-, sulfate (1:1) |
1639419-51-4 |
C18H22N8O2S.H2O4S |
 |
Botensilimab |
2408310-37-0 |
|
 |
Penpulimab |
2350298-92-7 |
|
 |
Rilvegostomig |
2640305-01-5 |
|
 |
Gefurulimab |
2456407-94-4 |
|
 |
ORGOTEIN |
9016-01-7 |
Cu4Zn4+16 |
 |
5,8,11,14,17-Pentaoxaheneicosa-2,19-dienedioic acid, 4,18-dioxo-, 1,21-dimethyl ester, (2E,19E)- |
1817769-42-8 |
C18H26O11 |
 |
Research Grade Valziflocept |
1804910-11-9 |
|
 |
pirtianol |
78092-66-7 |
C8H14NO5PS |
 |
Ro 32-3555 |
190648-49-8 |
C22H36N4O5 |
 |
Abatacept |
332348-12-6 |
|
 |
MeriMepodib, VI-21497, VX-497 |
198821-22-6 |
C23H24N4O6 |
 |
Zansecimab |
2415205-37-5 |
|
 |
Rocatinlimab |
2431972-52-8 |
|
 |
Emapticap pegol |
1390630-22-4 |
|
![[4-methyl-5-[(2E,4E)-5-phenylpenta-2,4-dienoyl]-1,3-thiazol-2-yl]thiourea](/) |
[4-methyl-5-[(2E,4E)-5-phenylpenta-2,4-dienoyl]-1,3-thiazol-2-yl]thiourea |
1236126-45-6 |
|
 |
Sabirnetug |
2747959-38-0 |
|
 |
Unii-9927mt646m |
179045-86-4 |
|
 |
Amiselimod(MT-1303) hydrochloride |
942398-84-7 |
C19H31ClF3NO3 |
![[1,1'-Biphenyl]-4-sulfonamide, 4'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-](/CAS/20200331/GIF/1642602-54-7.gif) |
[1,1'-Biphenyl]-4-sulfonamide, 4'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)- |
1642602-54-7 |
C20H21ClN2O3S |
 |
Ruclosporin |
882569-97-3 |
C68H122N12O14 |
 |
Rontalizumab |
948570-30-7 |
|
 |
Glenzocimab |
2101829-58-5 |
|
 |
Sasanlimab |
2206792-50-7 |
|
![8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)-](/CAS/20200611/GIF/1887069-10-4.gif) |
8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)- |
1887069-10-4 |
C22 H20 Cl N5 O3 S |
 |
Quavonlimab |
2254059-25-9 |
|
 |
Zeluvalimab |
2315361-37-4 |
|
 |
Sibeprenlimab |
2382896-07-1 |
|
 |
Uliledlimab |
2378407-27-1 |
|
![2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-, 4-methylbenzenesulfonate (1:1)](/CAS/20211123/GIF/2192215-81-7.gif) |
2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-, 4-methylbenzenesulfonate (1:1) |
2192215-81-7 |
C22H27N5O4S |
 |
Seprilose |
133692-55-4 |
C16H30O6 |
 |
Delpacibart |
2653183-66-3 |
|
 |
Research Grade Davoceticept (DHJ70122) |
2307144-64-3 |
|
 |
Research Grade Tobemstomig (DHD30409) |
2648839-43-2 |
|
 |
Peginterferon beta-1a |
1211327-92-2 |
|
 |
Melredableukin+alfa |
2056881-92-4 |
|
 |
Interleukin-4 |
207137-56-2 |
|
 |
1-(5-hydroxyhexyl)-3,7-dimethyl-purine-2,6-dione |
100324-81-0 |
C13H20N4O3 |
 |
Raxibacumab |
565451-13-0 |
|
 |
UMiroliMus |
851536-75-9 |
C55H87NO14 |
 |
Siplizumab |
288392-69-8 |
|
![Pifonakin [inn]](/) |
Pifonakin [inn] |
112721-39-8 |
|
 |
VisilizuMab |
219716-33-3 |
|
 |
Adavivint |
1467093-03-3 |
C29H24FN7O |
 |
Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer |
326859-36-3 |
|
 |
Sifalimumab |
1006877-41-3 |
|
 |
Anifrolumab |
1326232-46-5 |
|
 |
Birtamimab |
1608108-91-3 |
|
 |
Camrelizumab |
1798286-48-2 |
|
 |
Narsoplimab |
2108782-45-0 |
|
 |
Cosibelimab |
2216751-26-5 |
|
 |
Sonelokimab |
1414386-05-2 |
|
 |
oxycinchophen |
485-89-2 |
C16H11NO3 |
![4-Pyridinecarboxamide, 2-[[[(2R)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4-piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]-N,N,6-trimethyl-, hydrochloride (1:2)](/CAS/20211123/GIF/1372127-19-9.gif) |
4-Pyridinecarboxamide, 2-[[[(2R)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4-piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]-N,N,6-trimethyl-, hydrochloride (1:2) |
1372127-19-9 |
C27H35Cl2N5O3 |
 |
Nipocalimab |
2211985-36-1 |
|
 |
Amlitelimab |
2378692-15-8 |
|
 |
Pavunalimab |
2329669-78-3 |
|
 |
Temurtide |
66112-59-2 |
C20H34N4O12 |